GlassScriptPhysician profile
Doriann T Stempinski
NPI 1417477811
$7,319.11
in general payments reported to CMS, 2019-2025
44 companies · $1,887 in 2025
The $1,887 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,884 · 2022: $226 · 2023: $1,327 · 2024: $1,995 · 2025: $1,887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,209.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $799.98 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $684.45 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Amgen INC. | $557.50 | 2021-2025 | Otezla, Otezla, Evenity |
| Dexcom, INC. | $493.57 | 2023-2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $398.80 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $390.94 | 2021-2025 | Mounjaro, Trulicity, Jardiance |
| Gilead Sciences, INC. | $308.29 | 2024-2025 | Epclusa, Biktarvy |
| Sumitomo Pharma America, INC. | $303.45 | 2023-2025 | Gemtesa |
| Pfizer INC. | $286.28 | 2023-2025 | |
| Exact Sciences Corporation | $281.89 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $261.99 | 2023-2025 | |
| Sk Life Science, INC. | $226.71 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $200.94 | 2021-2025 | Eliquis, Camzyos |
| Allergan, INC. | $181.81 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $168.93 | 2021-2024 | Jardiance |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Doriann Stempinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.